IP Library › Patent Application 18543945
Patent Application Utility
App. No. 18/543,945 · Confirmation No. 5704

SUBSTITUTED INHIBITORS OF MENIN-MLL AND METHODS OF USE

Applicant: Kura Oncology, Inc.
Abandoned -- Incomplete Application (Pre-examination)
⬇ PDF
 Code Description Pages PDF
2024-09-26 ABN Abandonment 2 View
2024-08-23 N417 Electronic Filing System Acknowledgment Receipt 2 View
2024-08-23 N417.PYMT Electronic Fee Payment 2 View
2024-08-23 XT/ Extension of Time 1 View
2024-01-25 APP.FILE.REC Filing Receipt 4 View
2024-01-25 WCLM Claims Worksheet (PTO-2022) 2 View
2024-01-25 WFEE Fee Worksheet (SB06) 1 View
2024-01-25 NTC.MISS.PRT Notice to File Missing Parts 2 View
2024-01-25 WELCOME.LET Welcome Letter from USPTO Director and Deputy Director 1 View
2023-12-20 CRFE Sequence Listing in Computer Readable Format, No errors found — View
2023-12-20 CRFE Sequence Listing in Computer Readable Format, No errors found 5 View
2023-12-18 SPEC Specification — View
2023-12-18 TRNA Transmittal of New Application 2 View
2023-12-18 SPEC Specification 167 View
2023-12-18 CLM Claims 22 View
2023-12-18 ABST Abstract 1 View
2023-12-18 ADS Application Data Sheet 9 View
2023-12-18 DRW Drawings-only black and white line drawings 3 View
2023-12-18 OATH Oath or Declaration filed 3 View
2023-12-18 N417 Electronic Filing System Acknowledgment Receipt 3 View
2023-12-18 SEQ.XML Sequence Listing (XML File) 1 View
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
App. No.
18/543,945
Filed
2023-12-18